Assessment of Haematological Profile and CD4 Count of Patients with HIV Infection

Document Type : Original Article

Authors

Department of Medical Biochemistry, Gandhi Medical College, Bhopal, India

Abstract

Background and aim: Human Immunodeficiency Virus (HIV) infection is associated with morbidity and mortality worldwide. Anemia is the most common complication of HIV infection, which may be attributed to insufficient production of red blood cells. The present study was conducted to assess the hematological profile of HIV-positive patients irrespective of therapy and to establish a correlation with CD4 count.
Material and methods: The present observational study was conducted at a tertiary care center in central India for two years, from June 2019 to June 2021. Clinical findings were noted, followed by hematological and CD4 investigations by flow cytometry.
Results: Two hundred HIV-positive patients were enrolled; the mean age was 35.67±10.48 years. The majority of HIV patients, 80%, had anemia. Leukocytopenia and leukocytosis were documented in 10% and 7.5% of cases, and thrombocytopenia was noted in 22% of cases of HIV. About 49% of cases had a CD4 count of less than 200, and 40% of cases had a CD4 count in the range of 200 to 500. Statistically significant (P-value < 0.05) association of low CD4 count with loose motions, weight loss, pallor, anemia, neutrophilia, and low Mean corpuscular hemoglobin concentration (MCHC), were noted. Statistically significant (P-value < 0.05) positive CD4 counts with hemoglobin, lymphocytes, blood glucose, Mean corpuscular hemoglobin (MCH), and MCHC and a negative correlation with neutrophils were found.
Conclusions: The study showed an association between hematological abnormalities in patients with HIV. CD4 counts are useful for staging and assessing the prognosis of patients with HIV infection.

Keywords

Main Subjects


[1]  HIV/AIDS, Reproductive Health Matters. 2005;13(25):187–93 https://doi.org/10.1016/S0968-8080(05)25177-7.
[2]  Jackson BS, Pretorius E. Pathological clotting and deep vein thrombosis in patients with HIV. InSeminars in thrombosis and hemostasis 2019;45(2):132-40. https://doi.org/ 10.1055/s-0038-1676374.
[3]  Zon LI, Groopman JE. Hematologic manifestations of the human immune deficiency virus (HIV). InSeminars in hematology 1988;25(3):208-18.
[4]  Nonnemacher MR, Quiterio S, Allen AG, Mele AR, Pirrone V, Wigdahl B. Myelomonocytic cell lines in modeling HIV-1 infection of the bone marrow. Biology of Myelomonocytic Cells. InTech. 2017;10:129-62. http://dx.doi.org/10.5772/67596.
[5]  Mathews SE, Srivastava D, Yadav RB, Sharma A. Association of hematological profile of human immunodeficiency virus-positive patients with clinicoimmunologic stages of the disease. Journal of laboratory physicians. 2013;5(01):34-7. https://doi.org/10.4103/0974-2727.115929.
[6]  Vaillant AA, Gulick PG. HIV Disease Current Practice. 2020.
[7]  Parinitha SS, Kulkarni MH. Haematological changes in HIV infection with correlation to CD4 cell count. The Australasian medical journal. 2012;5(3):157-62. https:doi.org/ 10.4066/AMJ.20121008.
[8]  Sharika S, Jayapal T, Stephenson J, DS AR, Rajasekharan C. The clinical profile of patients diagnosed as having HIV infection with special reference to Joint manifestations and its correlation with CD4 count. International Journal of Health and Clinical Research. 2021;4(8):249-53.
[9]  Srinivasa Rao B, Jagannadham R, Manojna B. Relation between clinical profile, CD4 count and total lymphocyte count in HIV infected persons. Journal of Evidence Based Medicine and Healthcare. 2019; 6(52), 3225-9. https:doi.org/10.18410/jebmh/2019/677.
[10] Gange SJ, Lau B, Phair J, Riddler SA, Detels R, Margolick JB. Rapid declines in total lymphocyte count and hemoglobin in HIV infection begin at CD4 lymphocyte counts that justify antiretroviral therapy. Aids. 2003;17(1):119-21.
[11] Abebe M, Alemseged F. Hematologic abormalities among children on Haart, in Jimma university specialized hospital, southwestern ethiopia. Ethiopian Journal of Health Sciences. 2009;19(2):83-9. https:doi.org/10.4314/ejhs.v19i2.69420.
[12] Kibaru EG, Nduati R, Wamalwa D, Kariuki N. Impact of highly active antiretroviral therapy on hematological indices among HIV-1 infected children at Kenyatta National Hospital-Kenya: retrospective study. AIDS research and therapy. 2015;12(1):1-8. https://doi.org/10.1186/s12981-015-0069-4.
[13] Thulasi RR, Manimaran D, Hemanathan G, Afroz T, Sagar R. Hematological abnormalities in HIV infected individuals in correlation to CD4 counts and ART status. Asian Journal of Medical Sciences. 2016;7(4):14-8. https://doi.org/10.3126/ajms.v7i4.14033.
[14] Duguma N, Tesfaye Kiya G, Adissu Maleko W, Bimerew LG. Hematological parameters abnormalities and associated factors in HIV-positive adults before and after highly active antiretroviral treatment in Goba Referral Hospital, southeast Ethiopia: a cross-sectional study. SAGE open medicine. 2021. https://doi.org/10.1177/20503121211020175.
Volume 4, Issue 2
June 2022
Pages 45-51
  • Receive Date: 06 February 2022
  • Revise Date: 30 March 2022
  • Accept Date: 14 April 2022
  • First Publish Date: 17 April 2022